Safety issues around misuse of antiepileptics

Bibliography

• Sabate E. Adherence to long-term therapies: evidence for action. World Health Organization, Geneva; 2003
   Google Scholar
• Casati A, Sedefov R, Pfeiffer-Gerschel T. Misuse of medicines in the European union: a systematic review of the literature. Eur Addict Res 2012;18:228-45
   PubMed Web of Science ®Google Scholar
• Donmall M. UK monitoring of problem drug users: the drug misuse database–a system based on regional centres. Eur Addict Res 1999;5:185-90
   PubMed Web of Science ®Google Scholar
• Kaye S, Darke S. The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care? Addiction 2012;107:467-77
   PubMed Web of Science ®Google Scholar
• Nakhutina L, Gonzalez JS, Margolis SA, et al. Adherence to antiepileptic drugs an beliefs about medication among predominantly ethnic minority patients with epilepsy. Epilepsy Behav 2011;22:584-6
   PubMed Web of Science ®Google Scholar
• Glombiewski JA, Nestoriuc Y, Rief W, et al. Medication adherence in the general population. PloS One 2012;7:e50537
   PubMedGoogle Scholar
• Cramer JA, Glassman M, Rienzi V. The relationship between poor medication compliance and seizures. Epilepsy Behav 2002;3:338-42
   PubMed Web of Science ®Google Scholar
• Jonikas MA, Mandl KD. Surveillance of medication use: early identification of poor adherence. J Am Med Inform Assoc 2011;19:649-54
   PubMed Web of Science ®Google Scholar
• Davis KL, Candrilli SD, Edin HM. Prevalence and cost of nonadherence with antiepileptic drugs in and adult managed care population. Epilepsia 2008;49:446-54
   PubMed Web of Science ®Google Scholar
• Garnett WR. Antiepileptic drug treatment: outcomes and adherence. Pharmacotherapy 2000;20:191S-9S
   PubMed Web of Science ®Google Scholar
• Leppik IE. Compliance during treatment of epilepsy. Epilepsia 1988;29:S79-84
   PubMed Web of Science ®Google Scholar
• Manjunath R, Davis KL, Candrilli SD, Ettinger AB. Association of antiepileptic drug non adherence with risk of seizures in adults with epilepsy. Epilepsy Behav 2009;14:372-8
   PubMed Web of Science ®Google Scholar
• Ettinger AB, Manjunath R, Candrilli SD, Davis KL. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy Behav 2009;14:324-9
   PubMed Web of Science ®Google Scholar
• Faught E, Duh MS, Weiner JR, et al. Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study. Neurology 2008;71:1572-8
   PubMed Web of Science ®Google Scholar
• Brown I, Sheeran P, Reuber M. Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy Behav 2009;16:634-9
   PubMed Web of Science ®Google Scholar
• Eatock J, Baker GA. Managing patient adherence and quality of life in epilepsy. Neuropsychiatr Dis Treat 2007;3:117-31
   PubMedGoogle Scholar
• Harimanama A, Clavel S, Chivorakul P, et al. Associated factors with adherence to antiepileptic drug in the capital city of Lao PDR. Epilepsy Res 2013;104:158-66
   PubMed Web of Science ®Google Scholar
• Kyngas H. Compliance with health regimens of adolescents with epilepsy. Seizure 2000;9:598-604
   PubMed Web of Science ®Google Scholar
• Hovinga CA, Asato MR, Manjunath R, et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy Behav 2008;13:316-22
   PubMed Web of Science ®Google Scholar
• Modi AC, Rausch JR, Glauser TA. Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. JAMA 2011;305:1669-79
   PubMed Web of Science ®Google Scholar
• Modi AC, Morita DA, Glauser TA. One-month adherence in children with new-onset epilepsy: white-coat compliance does not occur. Pediatrics 2008;121:e961-6
   PubMed Web of Science ®Google Scholar
• Jarvie S, Espie CA, Brodie MJ. The development of a questionnaire to assess knowledge of epilepsy: 1--General knowledge of epilepsy. Seizure 1993;2:179-85
   PubMedGoogle Scholar
• Asadi-Pooya AA. Drug compliance of children and adolescents with epilepsy. Seizure 2005;14:393-5
   PubMed Web of Science ®Google Scholar
• Podsadecki TJ, Vrijens BC, Tousset EP, et al. "White coat compliance" limits the reliability of therapeutic drug monitoring in HIV-1-infected patients. HIV Clin Trials 2008;9:238-46
   PubMed Web of Science ®Google Scholar
• Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990;150:1509-10
   PubMed Web of Science ®Google Scholar
• Carpentier N, Jonas J, Frismand S, et al. Direct evidence of nonadherence to antiepileptic medication in refractory focal epilepsy. Epilepsia 2013;54:e20-3
   PubMed Web of Science ®Google Scholar
• Sweileh WM, Ihbesheh MS, Jarar IS, et al. Self-reported medication adherence and treatment satisfaction in patients with epilepsy. Epilepsy Behav 2011;21:301-5
   PubMed Web of Science ®Google Scholar
• Collins NS, Shapiro RA, Ramsay RE. Elders with epilepsy. Med Clin North Am 2006;90:945-66
   PubMed Web of Science ®Google Scholar
• Sheorajpanday RV, De Deyn PP. Epileptic fits and epilepsy in the elderly: general reflections, specific issues and therapeutic implications. Clin Neurol Neurosurg 2007;109:727-43
   PubMed Web of Science ®Google Scholar
• Chen LA, Cheng SJ, Jou SB. Epilepsy in the Elderly. Int J Gerontol 2012;6:63-7
   Web of Science ®Google Scholar
• Cloyd J, Hauser W, Towne A, et al. Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Res 2006;68(Suppl 1):s39-48
   PubMedGoogle Scholar
• Ettinger AB, Baker GA. Best clinical and research practice in epilepsy of older people: focus on antiepileptic drug adherence. Epilepsy Behav 2009;15(Suppl 1):s60-3
   PubMedGoogle Scholar
• Brodie MJ, Kwan P. Epilepsy in elderly people. BMJ 2005;331:1317-22
   PubMed Web of Science ®Google Scholar
• Neufeld MY, Vishne T, Chistik V, Korczyn AD. Life-long history of injuries related to seizures. Epilepsy Res 1999;34:123-7
   PubMed Web of Science ®Google Scholar
• Lackner TE. Strategies for optimizing antiepileptic drug therapy in elderly people. Pharmacotherapy 2002;22:329-64
   PubMed Web of Science ®Google Scholar
• French JA, Staley BA. AED treatment through different ages: as our brains change, should our drug choices also? Epilepsy Curr 2012;12(Suppl 3):22-7
   PubMedGoogle Scholar
• Kanner AM, Nieto JC. Depressive disorders in epilepsy. Neurology 1999;53(Suppl 2):S26-32
   PubMedGoogle Scholar
• Mula M, Sander JW. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf 2007;30:555-67
   PubMed Web of Science ®Google Scholar
• Borthen I, Eide MG, Veiby G, et al. Complications during pregnancy in women with epilepsy: population-based cohort study. BJOG 2009;116:1736-42
   PubMed Web of Science ®Google Scholar
• Tomson T, Battino D, Bonizzoni E, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609-17
   PubMed Web of Science ®Google Scholar
• Montouris G. Importance of monotherapy in women across the reproductive cycle. Neurology 2007;69:S10-16
   PubMed Web of Science ®Google Scholar
• Williams J, Myson V, Steward S, et al. Self-discontinuation of antiepileptic medication in pregnancy: detection by hair analysis. Epilepsia 2002;43:824-31
   PubMed Web of Science ®Google Scholar
• Man SL, Petersen I, Thompson M, Nazareth I. Antiepileptic drugs during pregnancy in primary care: a UK population based study. Plos One 2012;7:e52339
   PubMedGoogle Scholar
• Matsui D. Adherence with drug therapy in pregnancy. Obstet Gynecol Int 2012;2012:1-5
   Google Scholar
• Tomson T, Landmark CJ, Battino D. Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications. Epilepsia 2013;54:405-14
   PubMed Web of Science ®Google Scholar
• Tomson T, Battino D. Teratogenic effects of antiepileptic drugs. Lancet Neurol 2012;11:803-13
   PubMed Web of Science ®Google Scholar
• Tatum WO. Use of antiepileptic drugs in pregnancy. Expert Rev Neurother 2006;6:1077-86
   PubMedGoogle Scholar
• Kulaga S, Sheehy O, Zargarzadeh AH, et al. Antiepileptic drug use during pregnancy: perinatal outcomes. Seizure 2011;20:667-72
   PubMed Web of Science ®Google Scholar
• Adab N, Kini U, Vinten J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004;75:1575-83
   PubMed Web of Science ®Google Scholar
• Pennell PB. The importance of monotherapy in pregnancy. Neurology 2003;60(Suppl4):S31-8
   PubMedGoogle Scholar
• Artama M, Auvinen A, Raudaskoski T, et al. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 2005;64:1874-8
   PubMed Web of Science ®Google Scholar
• Pennell PB. Pregnancy in women who have epilepsy. Neurol Clin 2004;22:799-820
   PubMed Web of Science ®Google Scholar
• Rauchenzauner M, Ehrensberger M, Prieschl M, et al. Generalized tonic-clonic seizure and antiepileptic drugs during pregnancy–a matter of importance for the baby? J Neurol 2012;260:484-8
   PubMed Web of Science ®Google Scholar
• O'Connor SE, Zupanc ML. Women and epilepsy. J Pediatr Pharmacol Ther 2009;14:212-20
   Google Scholar
• Khasro I, Rahma S. Drug compliance in epileptic children in Sulaymani Governate. Iraqi Postgr Med J 2010;9:158-62
   Google Scholar
• Kyngas H. Predictors of good compliance in adolescents with epilepsy. Seizure 2001;10:549-53
   PubMed Web of Science ®Google Scholar
• Mitchell WG, Scheier LM, Baker SA. Adherence to treatment in children with epilepsy: who follows ”doctor's orders”? Epilepsia 2000;41:1616-25
   PubMed Web of Science ®Google Scholar
• Bandstra NF, Camfield CS, Camfield PF. Stigma of epilepsy. Can J Neurol Sci 2008;35:436-40
   PubMed Web of Science ®Google Scholar
• Shore CP, Buelow JM, Austin JK, Johnson CS. Continuing psychosocial care needs in children with new-onset epilepsy and their parents. J Neurosci Nurs 2009;41:244-50
   PubMed Web of Science ®Google Scholar
• Dilorio C, Osborne Shafer P, Letz R, et al. The association of stigma with self-management and perceptions of health care among adults with epilepsy. Epilepsy Behav 2003;4:259-67
   PubMed Web of Science ®Google Scholar
• Helde G, Bovin G, Brather G, et al. A structured, nurse led intervention program improves quality of life in patients with epilepsy: a randomized, controlled trial. Epilepsy Behav 2005;7:451-7
   PubMed Web of Science ®Google Scholar
• Greenhill L, Betts T, Pickard N. The epilepsy nurse specialists-expendable handmaiden or essential colleague? Seizure 2001;10:623-4
   Google Scholar
• Mahret-Imhof R, Jaggi S, Bonomo A, et al. Quality of life in adult patients with epilepsy and their family members. Seizure 2013;22:28-35
   PubMedGoogle Scholar
• Hovinga CA, Asato MR, Manjunath R, et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy Behav 2008;13:316-22
   PubMed Web of Science ®Google Scholar
• Muclow JC, Dollery CT. Compliance with anticonvulsant therapy in a hospital clinic and in the community. Br J Clin Pharmacol 1978;6:75-9
   PubMed Web of Science ®Google Scholar
• Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296-310
   PubMed Web of Science ®Google Scholar
• Haag A, Strzelczyk A, Bauer S, et al. Quality of life and employment status are correlated with antiepileptic monotherapy versus politherapy and not with use of “newer” versus “classic” drugs: results of the “Compliant 2006” survey in 907 patients. Epilepsy Behav 2010;19:618-22
   PubMed Web of Science ®Google Scholar
• Kariyawasam SH, Bandara N, Koralagama A, Senanayake S. Challenging epilepsy with antiepileptic pharmacotherapy in a tertiary teaching hospital in Sri Lanka. Neurol India 2004;52:233-7
   PubMed Web of Science ®Google Scholar
• Arlt S, Lindner R, Rosler A, von Renteln-Kruse W. Adherence to medication in patients with dementia: predictors and strategies for improvement. Drugs Aging 2008;25:1033-47
   PubMed Web of Science ®Google Scholar
• DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: metaanalysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101-7
   PubMed Web of Science ®Google Scholar
• Chen HF, Tsai YF, Lin YP, et al. The relationship among medicine symptom distress, selfefficacy, patient-provider relationship, and medication compliance in patients with epilepsy. Epilepsy Behav 2010;19:43-9
   PubMed Web of Science ®Google Scholar
• Fraser RT, Johnson EK, Miller JW, et al. Managing epilepsy well: self – management needs assessment. Epilepsy Behav 2011;20:291-8
   PubMed Web of Science ®Google Scholar
• Modi AC, Wu YP, Guilfoyle SM, Glauser TA. Uninformed clinical decisions resulting from lack of adherence assessment in children with new-onset epilepsy. Epilepsy Behav 2012;25:484-
   Google Scholar
• Bautista RE, Rundle–Gonzalez V. Effects of antiepileptic drug characteristics on medication adherence. Epilepsy Behav 2012;23:437-41
   PubMed Web of Science ®Google Scholar
• Smithson WH, Hukins D, Colwell B, Mathers N. Developing a method to identify medicines non-adherence in a community sample of adults with epilepsy. Epilepsy Behav 2012;24:49-53
   PubMed Web of Science ®Google Scholar
• Faught E. Adherence to antiepilepsy drug therapy. Epilepsy Behav 2012;25:297-302
   PubMed Web of Science ®Google Scholar
• Faught RE, Weiner JR, Guerin A, et al. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study. Epilepsia 2009;50:501-9
   PubMed Web of Science ®Google Scholar
• Jones RM, Butler JA, Thomas VA, et al. Adherence to treatment in patients with epilepsy: associations with seizure control and illness beliefs. Seizure 2006;15:504-8
   PubMed Web of Science ®Google Scholar
• Johannessen Landmark C, Larsson PG, Rytter E, Johannessen SI. Antiepileptic drugs in epilepsy and other disorders–a population-based study of prescriptions. Epilepsy Res 2009;87:31-9
   PubMed Web of Science ®Google Scholar
• Mondon S, Nogue S, Urbano D, Rovira E. [Gabapentin abuse].[Article in Spanish]. Med Clin (Barc) 2010;134:138-9
   PubMedGoogle Scholar
• Grosshans M, Mutschler J, Hermann D, et al. Pregabalin abuse, dependence, and with-drawal: a case report. Am J Psychiatry 2010;167:869
   PubMed Web of Science ®Google Scholar
• Webb J. Gabapentin–another drug of misuse? BCPhA Tablet 2008;17:12-13
   Google Scholar
• Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry 2002;63:384-90
   PubMed Web of Science ®Google Scholar
• Sajatovic M, Valenstein M, Blow F, et al. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr Serv 2007;58:855-63
   PubMed Web of Science ®Google Scholar
• Frauger E, Pauly V, Pradel V, et al. Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network. Fundam Clin Pharmacol 2011;25:633-41
   PubMed Web of Science ®Google Scholar
• Filipetto FA, Zipp CP, Coren JS. Potential for pregabalin abuse or diversion after past drug-seeking behavior. J Am Osteopath Assoc 2010;110:605-7
   PubMedGoogle Scholar
• Schifano F, D'Offizi S, Piccione M, et al. Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data. Psychother Psychosom 2011;80:118-22
   PubMed Web of Science ®Google Scholar
• Sinha S, Siddiqui KA. Definition of intractable epilepsy. Neurosciences (Riyadh) 2011;16:3-9
   PubMed Web of Science ®Google Scholar
• Liu L, Yiu CH, Yen DJ, et al. Medication education for patients with epilepsy in Taiwan. Seizure 2003;12:473-7
   PubMed Web of Science ®Google Scholar